Oct 16 (Reuters) - Recce Pharmaceuticals Ltd (RCE) :
- HREC APPROVAL TO START PHASE I/II BURNS WOUND STUDY-RCE.AX
- GOT HUMAN RESEARCH ETHICS COMMITTEE APPROVAL TO START PHASE I/II CLINICAL TRIAL OF ITS BROAD-SPECTRUM ANTIBIOTIC RECCE 327
Oct 16 (Reuters) - Recce Pharmaceuticals Ltd (RCE) : HREC...
Add to My Watchlist
What is My Watchlist?